हिन्दी ಕನ್ನಡ తెలుగు मराठी ગુજરાતી বাংলা ਪੰਜਾਬੀ தமிழ் অসমীয়া മലയാളം मनी9 TV9 UP
Bihar 2025 India Sports Tech World Business Career Religion Entertainment LifeStyle Photos Shorts Education Science Cities Videos

Sudeep Pharma IPO: Fully subscribed on day 1; GMP strong | Check key details

On Nov 21, the first day of bidding, the Sudeep Pharma IPO was subscribed 1.43 times overall, with retail investors bidding for 153%of the shares earmarked for them. The GMP is signalling a nearly 20% listing gain on early morning of Nov 22, the second day of the bidding process.

On the first day of bidding retail investors have bid for more than 150% of the shares earmarked for them.
| Updated on: Nov 22, 2025 | 08:55 AM

Kolkata: Sudeep Pharma IPO had a decent first day of bidding -- it was subscribed 1.43 times overall. The issue was subscribed 1.53 times in the retail category, 0.09 times in QIB (ex anchor) category and 3.01 times in the NII category by the end of November 21. The company intends to mobilise Rs 895 crore through a combination fresh issue of 0.16 crore shares aggregating to Rs 95 crores and an OFS part to raise Rs 800 crores.

Sudeep Pharma is headquartered in Vadodara of Gujarat and is strongly rooted in the business of manufacturing pharmaceutical excipients, food-grade minerals and specialty nutrition ingredients. It has customers spread over more than 100 countries. It also had significant success with the anchor round of investment when it managed to raise Rs 268.5 crore from anchor investors, the list of which featured names such as SBI Mutual Fund (MF), HDFC MF, ICICI Prudential MF, Nippon India MF, WhiteOak Capital MF, Aditya Birla Sun Life MF, Motilal Oswal MF, Quant MF, Bandhan MF, UTI MF, Edelweiss MF, Tata AIA Life Insurance and SBI Life Insurance. The company allocated 45,27,823 equity shares at Rs 593 per share to anchor investors.

Also Read

It counts Pfizer Inc., Mankind Pharma, Merck Group, Aurobindo Pharma, Cadila Pharmaceutical, IMCD Asia Pte Ltd and Danone SA are among the long-standing customers of the company. The company will use the proceeds of the sale of fresh shares (Rs 75.81 crore) for purchase of machinery and general corporate purposes.

Sudeep Pharma IPO GMP

According to investorgain, in early morning of Nov 22, the Sudeep Pharma IPO GMP was recorded at Rs 115. At this level it indicated a probable listing gain of 19.39%. The GMP stood at Rs 93 on Nov 18 and Rs jumped to Rs 130 on Nov 19 before reaching Rs 122 on Nov 20. However, it must be remembered that GMP is an unofficial indicator, is extremely volatile and cannot guarantee listing gain or loss.

Sudeep Pharma IPO price band, lot size, key dates

Sudeep Pharma IPO price band is Rs 563-593. For a retail investor the minimum investible lot has of 25 shares for which he/she has to pay an application money of Rs 14,825 based on the upper end of the price band. On the other hand, the minimum investible lot for sNII investors is 350 shares, while the minimum lot for bNII category of investors is 1,700 shares. ICICI Securities is the lead manager and MUFG Intime India the registrar for the issue.

IPO closes: Nov 25, 2025

Allotment: Nov 26

Refund: Nov 27

Credit of shares to demat: Nov 27

Listing: Nov 28

Cut-off time for UPI mandate confirmation: 5 pm on Nov 25

Disclaimer: This article is only meant to provide information. TV9 does not recommend buying or selling shares or subscriptions of any IPO, Mutual Funds, precious metals, commodity, REITs, INVITs, any form of alternative investment instruments and crypto assets.

Photo Gallery

Entertainment

World

Sports

Lifestyle

India

Technology

Business

Religion

Shorts

Career

Videos

Education

Science

Cities